CPIG
IMGN

Chicago Partners Investment Group’s Immunogen Inc IMGN Stock Holding History

Chicago Partners Investment Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,873
Closed -$350K – 763
2023
Q4 		$350K Buy
+11,873
New +$236K 0.02% 507
2023
Q2 		– Sell
-25,482
Closed -$103K – 722
2023
Q1 		$103K Buy
25,482
+3,076
+14% +$13.1K 0.01% 643
2022
Q4 		$107K Sell
22,406
-388
-2% -$2.1K 0.01% 617
2022
Q3 		$130K Buy
22,794
+2,099
+10% +$11.1K 0.01% 555
2022
Q2 		$98K Sell
20,695
-161
-0.8% -$699 0.01% 570
2022
Q1 		$73K Sell
20,856
-1,538
-7% -$8.52K 0.01% 546
2021
Q4 		$124K Sell
22,394
-8,023
-26% -$49.9K 0.01% 541
2021
Q3 		$172K Sell
30,417
-520
-2% -$3K 0.01% 558
2021
Q2 		$172K Buy
30,937
+6,460
+26% +$45.1K 0.01% 509
2021
Q1 		$199K Buy
+24,477
New +$200K 0.02% 495

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Chicago Partners Investment Group's IMGN Position: Q1 2024 in Review

Chicago Partners Investment Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 11,873 shares — an estimated $350K sold.

Chicago Partners Investment Group first reported a position in IMGN in Q1 2021 and held it in 10 quarters. The position peaked at $350K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Chicago Partners Investment Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Chicago Partners Investment Group sold 11,873 Immunogen Inc shares in Q1 2024, an estimated $350K.
  • Chicago Partners Investment Group first reported a position in Immunogen Inc in Q1 2021 and held it in 10 quarters.
  • Chicago Partners Investment Group's Immunogen Inc position peaked at $350K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Chicago Partners Investment Group's 13F filing for Q1 2024, filed 25 Apr 2024.